Member Info for Livedataaccount

And also lack of buzz around the company.

A lot of trust has gone from the CEO'S talk. I suspect investors want to see tangible progress from Avacta.

Mr Smith also needs to be clear and upfront about timelines

Do you guys seriously thing Mr Smith is using AI?

I think it would be beneficial if AS adopts an American accent for the presentation and q and a. Avacta really need to concentrate on the US market.

So, Avacta have dumped investormeetscompany?

Katie pilbeam moderating the q and a

https://www.katiepilbeam.com/

Yep, do get the impression it's one individual that has become obsessed

What are you up expecting Mr Smith to say?

It's all in the RNS's.

Totally agree. Like it or not the outstanding Science (or company) is on the AIM market. And that brings with it a wild west reputation.

What's needed is a some savvy leadership to navigate. And I'm not convinced Avacta has that. Not saying the science won't prevail. But going by past experiences I would vote for a new CEO.

Moniman, that is one of the most stupid posts I've read on this forum. Amd that takes some doing.

Or to put it another way. If the share price remains at 50 pence when the next instalment is due.

Mr Smith and his trail blazing CEO will be diluting the company by circa 2%!! (7 millions shares) for one quarterly payment.

Happy to be corrected if if I'm misunderstanding.

Whilst everyone is dreaming of m and a and takeovers. I have a question a little closer to home.

Do Mr Smith and his trail blazing CFO now have to renogiate the terms of the bond with the share price crashing below the original deal price? Or is it just a case or allocating enough shares to pay back in the next instalment? By past instalments it's going to be around 7 million shares at this price. Not an insignificant amount of shares for one quarterly payment.

Or there is muted demand as the share has had the stuffing knocked out of it and sentiment has gone for now? Shareholders that have followed the company are rightly sceptical of Avacta's comms. I shouldn't think any of this bothers Mr Smith and the top management. Their remuneration isn't linked to share proce.

Pl75 dodgy

I also have concerns about the lack of volume since the new shares came onto the market last Tuesday. There is obviously going to be some churn for a while but I get the impression retail investors, and let's face it that's pretty much all Smith has have become very cautious of any news flow Avacta release.

That is not good and something Avacta communications need to sort out.

This is brilliant. But also, I find posts like this frustrating.

It seems the Science is fantastic. But Avacta's problem is the 'plc' side and being on AIM.

I just don't have faith in the CEO or his money advisors.

Hmm, this sounds like a question for a Vox interview.

Bella. Alan mentioned this in the Vox interview.

Precision can work with more toxic drugs.

I only hope he targets low hanging fruit first and doesn't mess this project up

Agreed, but it is unlikely to move the SP.

No one can agree whether the 2 weekly has even started yet? Screening started in December by Avacta said screening ongoing in Feb. 2 weekly is needed for the phase 2 or is it 1b? Lots of debate about whether it's phase 2 starting in q4 or phase 1b. Avacta's wording is Does expansion followed by phase 2. As usual clear as mud.

What annoys me is the targets avacta set are missed by months and sometimes years. And yet there's never any mention or comeback on why?

Gje. I think they were probably not screening in earnest in December. It was probably further off than the Avacta communications team wanted to make out. Avacta's use of languages in RNS'S is downright awful